Total Payments
$9,683
2024 Payments
$795.50
Companies
36
Transactions
368
Medicare Patients
7,788
Medicare Billing
$890,672
Payment Breakdown by Category
Food & Beverage$9,450 (97.6%)
Education$231.72 (2.4%)
Other$1.41 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,450 | 356 | 97.6% |
| Education | $231.72 | 9 | 2.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.41 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,913 | 64 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,021 | 68 | $0 (2024) |
| PFIZER INC. | $838.04 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $718.03 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $679.43 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $527.60 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $505.75 | 31 | $0 (2024) |
| Amarin Pharma Inc. | $496.09 | 18 | $0 (2021) |
| Esperion Therapeutics, Inc. | $444.47 | 13 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $229.51 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $795.50 | 43 | Amgen Inc. ($206.91) |
| 2023 | $720.12 | 29 | Amgen Inc. ($190.91) |
| 2022 | $891.76 | 37 | CVRx, Inc. ($164.33) |
| 2021 | $831.75 | 32 | Amgen Inc. ($237.97) |
| 2020 | $742.68 | 28 | Amgen Inc. ($241.86) |
| 2019 | $1,623 | 62 | Amgen Inc. ($452.58) |
| 2018 | $2,198 | 70 | Amgen Inc. ($371.67) |
| 2017 | $1,880 | 67 | E.R. Squibb & Sons, L.L.C. ($374.15) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.87 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $33.41 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.86 | General |
| Category: Cardiovascular | ||||||
| 10/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $6.14 | General |
| Category: Cardiovascular | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.76 | General |
| Category: Cardiovascular | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $1.92 | General |
| Category: Cardiovascular | ||||||
| 09/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.36 | General |
| Category: Cardiovascular | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.19 | General |
| Category: Cardiovascular | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.93 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Cardiology | ||||||
| 07/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: Cardiology | ||||||
| 07/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiology | ||||||
| 07/25/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $119.89 | General |
| Category: Vascular | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.19 | General |
| Category: Cardiovascular | ||||||
| 06/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $2.22 | General |
| Category: Cardiovascular | ||||||
| 05/29/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $72.88 | General |
| Category: NEUROLOGY | ||||||
| 05/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: Cardiology | ||||||
| 05/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: Cardiology | ||||||
| 05/16/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Cardiology | ||||||
| 05/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,686 | 2,475 | $640,290 | $194,686 |
| 2022 | 15 | 1,634 | 2,458 | $677,185 | $198,988 |
| 2021 | 18 | 2,163 | 3,089 | $845,800 | $253,303 |
| 2020 | 17 | 2,305 | 3,266 | $895,125 | $243,695 |
Total Patients
7,788
Total Services
11,288
Medicare Billing
$890,672
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 508 | 1,050 | $262,625 | $91,489 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 180 | 218 | $69,760 | $27,663 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 142 | 143 | $119,405 | $20,141 | 16.9% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 27 | 27 | $27,200 | $18,221 | 67.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 130 | $26,000 | $8,884 | 34.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 49 | 49 | $22,050 | $7,488 | 34.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 432 | 499 | $29,940 | $4,978 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,700 | $2,515 | 32.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 15 | 15 | $10,500 | $2,282 | 21.7% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 45 | 45 | $15,750 | $2,219 | 14.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 16 | $6,000 | $1,490 | 24.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,225 | $1,488 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 21 | $6,300 | $1,298 | 20.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 26 | 26 | $9,880 | $1,243 | 12.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 19 | 19 | $8,455 | $972.38 | 11.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 17 | 17 | $5,100 | $900.72 | 17.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 13 | 60 | $1,800 | $550.20 | 30.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 27 | 27 | $5,400 | $527.23 | 9.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 16 | 80 | $1,200 | $336.00 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 534 | 1,192 | $298,000 | $109,360 | 36.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 151 | 153 | $126,195 | $19,927 | 15.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 129 | 150 | $48,000 | $19,398 | 40.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 21 | 21 | $42,900 | $15,401 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 50 | 50 | $22,500 | $7,537 | 33.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 56 | 93 | $27,900 | $4,968 | 17.8% |
About Dr. John Smith, MD
Dr. John Smith, MD is a Cardiovascular Disease healthcare provider based in Mcdonough, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023054806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Smith, MD has received a total of $9,683 in payments from pharmaceutical and medical device companies, with $795.50 received in 2024. These payments were reported across 368 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($9,450).
As a Medicare-enrolled provider, Smith has provided services to 7,788 Medicare beneficiaries, totaling 11,288 services with total Medicare billing of $890,672. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine
- Location Mcdonough, GA
- Active Since 06/21/2006
- Last Updated 02/22/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1023054806
Products in Payments
- Repatha (Biological) $1,816
- ELIQUIS (Drug) $1,400
- XARELTO (Drug) $590.67
- ENTRESTO (Drug) $582.25
- Vascepa (Drug) $496.09
- JARDIANCE (Drug) $419.47
- FARXIGA (Drug) $347.07
- PRADAXA (Drug) $298.56
- NEXLIZET (Drug) $249.06
- VYNDAQEL (Drug) $231.48
- LifeVest (Device) $219.97
- NEXLETOL (Drug) $195.41
- Barostim Neo System (Device) $185.86
- BRILINTA (Drug) $178.47
- Adempas (Drug) $166.57
- PRALUENT ALIROCUMAB INJECTION (Biological) $155.13
- ORENITRAM (Drug) $153.89
- MITRACLIP (Device) $150.73
- FFRct (Device) $146.10
- VERQUVO (Drug) $140.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Mcdonough
Dr. Akshay Gupta, Md, MD
Cardiovascular Disease — Payments: $52,442
Cardiovascular Disease $52,442
Dr. Gregory Petro, Md, MD
Cardiovascular Disease — Payments: $26,582
Cardiovascular Disease $26,582
Homayoun Amin, M.d, M.D
Cardiovascular Disease — Payments: $8,366
Cardiovascular Disease $8,366
Dr. Srinivasa Chennareddy, M.d, M.D
Cardiovascular Disease — Payments: $7,696
Cardiovascular Disease $7,696
Mrs. Camille Nelson, Md, MD
Cardiovascular Disease — Payments: $5,650
Cardiovascular Disease $5,650
Rajasekhar Reddy, M.d, M.D
Cardiovascular Disease — Payments: $5,199
Cardiovascular Disease $5,199